Stocks-MED.US-Medifast Inc

MED.US Medifast Inc

18.90 0.13 (0.69%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

Overview

Prev Close 18.90
Day's Range 18.60 - 19.21
52 Week Range 17.58 - 83.34
Average Volume (3M) 438.93K
1-Year Return -77.12%
Beta0.9657
Market Cap 206.72M
P/E Ratio7.05
Revenue770.18M
EPS2.681
Dividend (Yield) 6.59 (34.87%)
Industry
Miscellaneous Commercial Services
CEO
Daniel R. Chard, MBA
Employees
634

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Medifast Inc's revenues decreased by 32.94% and amounted to 1.07B. Net income decreased by 30.75% to 99.42M. Net assets increased by 19.41% to 185.14M and EPS decreased from 12.73 to 9.10.
MED.US's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/24-50M050M100M150M200M250M
Gross Margin
73.94%
Net Profit Margin
10.18%
Operating Margin
4.45%
Return On Investment
65.88%
09/23
12/23
03/24
06/24
Total Revenue
235.87M
191.02M
174.74M
168.56M
Gross Profit
177.38M
141.37M
127.29M
123.44M
Operating Income
25.51M
8.68M
7.94M
-7.88M
Net Income
23.13M
6.04M
8.32M
-8.15M